Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Rydex Series - Health Care Fund

+ Add to Watchlist

RYHCX:US

28.63 USD 0.43 1.48%

As of 09:29:30 ET on 01/30/2015.

Snapshot for Rydex Series - Health Care Fund (RYHCX)

Year To Date: +2.32% 3-Month: +5.15% 3-Year: +24.89% 52-Week Range: 22.44 - 29.34
1-Month: +2.32% 1-Year: +22.65% 5-Year: +17.93% Beta vs SPX: 0.94

Mutual Fund Chart for RYHCX

No chart data available.
  • RYHCX:US 28.63
  • 1M
  • 1Y
Interactive RYHCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for RYHCX

Rydex Series-Health Care Fund is an open-end fund incorporated in the USA. The Fund's objective is to provide capital appreciation. The Fund invests substantially all of its assets in equity securities of health care companies that are traded in the U.S.

Inception Date: 03-30-2001 Telephone: 1-301-296-5100
Managers: MICHAEL PAUL BYRUM / RYAN HARDER
Web Site: www.guggenheiminvestments.com

Fundamentals for RYHCX

NAV (on 2015-01-30) 28.63
Assets (M) (on 2015-01-30) 250.59
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for RYHCX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-11-18) 0.07
Dividend Yield (ttm) 1.25

Fees & Expenses for RYHCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.85
Redemption Fee 0.00
12b1 Fee 1.00
Expense Ratio 2.37

Top Fund Holdings for RYHCX

Filing Date: 12/31/2014
Name Position Value % of Total
Johnson & Johnson 71,106 7,435,554 3.221%
Pfizer Inc 194,637 6,062,943 2.626%
Merck & Co Inc 96,520 5,481,371 2.374%
Gilead Sciences Inc 53,315 5,025,472 2.177%
Amgen Inc 29,970 4,773,921 2.068%
UnitedHealth Group Inc 43,455 4,392,866 1.903%
AbbVie Inc 66,764 4,369,036 1.892%
Bristol-Myers Squibb Co 73,146 4,317,808 1.870%
Celgene Corp 37,143 4,154,816 1.800%
Biogen Idec Inc 11,938 4,052,354 1.755%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil